Delta Asset Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Delta Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-200	Closed	-$1K	–	624
2019 Q3	$1K	Hold	200	–	–	﹤0.01%	599
2019 Q2	$2K	Hold	200	–	–	﹤0.01%	525
2019 Q1	$3K	Hold	200	–	–	﹤0.01%	498
2018 Q4	$3K	Hold	200	–	–	﹤0.01%	567
2018 Q3	$4K	Hold	200	–	–	﹤0.01%	563
2018 Q2	$5K	Hold	200	–	–	﹤0.01%	539
2018 Q1	$3K	Hold	200	–	–	﹤0.01%	582
2017 Q4	$4K	Hold	200	–	–	﹤0.01%	541
2017 Q3	$4K	Sell	200 -213	-52%	-$4.79K	﹤0.01%	514
2017 Q2	$14K	Hold	413	–	–	﹤0.01%	378
2017 Q1	$13K	Hold	413	–	–	﹤0.01%	389
2016 Q4	$15K	Hold	413	–	–	﹤0.01%	363
2016 Q3	$19K	Hold	413	–	–	﹤0.01%	331
2016 Q2	$21K	Hold	413	–	–	﹤0.01%	324
2016 Q1	$22K	Hold	413	–	–	﹤0.01%	315
2015 Q4	$27K	Buy	413 +63	+18%	+$3.89K	0.01%	294
2015 Q3	$19K	Hold	350	–	–	﹤0.01%	335
2015 Q2	$21K	Sell	350 -200	-36%	-$12.3K	﹤0.01%	332
2015 Q1	$34K	Hold	550	–	–	0.01%	274
2014 Q4	$32K	Hold	550	–	–	0.01%	290
2014 Q3	$30K	Hold	550	–	–	0.01%	286
2014 Q2	$29K	Hold	550	–	–	0.01%	289
2014 Q1	$29K	Hold	550	–	–	0.01%	285
2013 Q4	$22K	Buy	550 +150	+38%	+$5.91K	﹤0.01%	316
2013 Q3	$15K	Hold	400	–	–	﹤0.01%	355
2013 Q2	$16K	Buy	+400	New	+$15.6K	﹤0.01%	353

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

Delta Asset Management's TEVA Position: Q4 2019 in Review

Delta Asset Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2019, closing a stake of 200 shares — an estimated $1K sold.

Delta Asset Management first reported a position in TEVA in Q2 2013 and held it in 26 quarters. The position peaked at $34K in Q1 2015. 437 funds tracked by Wall St. Rank hold TEVA as of Q4 2019.

Delta Asset Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2019 after selling out during the quarter.
Delta Asset Management sold 200 Teva Pharmaceutical Industries Limited shares in Q4 2019, an estimated $1K.
Delta Asset Management first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and held it in 26 quarters.
Delta Asset Management's Teva Pharmaceutical Industries Limited position peaked at $34K in Q1 2015.
437 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2019.

Based on Delta Asset Management's 13F filing for Q4 2019, filed 31 Jan 2020.